go to healthmatters home page

Serious coverage of today's health service and public health issues

Originally published in healthmatters issue 18, Summer 1994, page 3
News

Secret genetic engineering produces high nicotine tobacco

Evidence that genetic engineering has been used to double the nicotine content of tobacco leaf emerged during recent congressional hearings in the US.

Tobacco industry chiefs were told they could face criminal proceedings for ‘deliberately misleading Congress’ as a result.

Dr David Kessler, commissioner of the US Food and Drug Administration, told congress that the Brown and Williamson corporation had engineered a new strain of tobacco, known as Y-1, which contains 6.2 per cent nicotine. Flue-cured tobacco usually contains 2.4 to 3 per cent nicotine.

‘This plant represents a dramatic attempt to manipulate nicotine,’ Dr Kessler told the congressional health and energy committee.

The production of the strain is widely regarded as an attempt to produce a more addictive cigarette which would be harder to quit or switch from.

The company has downplayed the significance of the allegations, saying that the new strain was originally developed by the US Agriculture Department ‘years ago’.

Meanwhile, the tobacco industry is hitting back at growing legal curbs on public smoking in the US, claiming that the government is ‘pursuing a new era of prohibition’.

‘Today it’s cigarettes. Tomorrow — will alcohol be next? Will caffeine be next? Will high fat foods be next?’, say newspaper adverts placed by the RJ Reynolds tobacco company.

Alex Campbell

More from

More about

More by Alex Campbell

Story search

 

Tip: use fewer, more specific words for a better search.

Feedback

What's your view on the issues raised here? Let us know what you think.

Send us your comments.

Get a free t-shirt!

Get a free t-shirt when you subscribe – or choose from our selection of free gifts

Choose a free gift when you subscribe

This page

This work is licensed under a Creative Commons License.

Creative Commons Licence

© healthmatters publications ltd.

Non-profitmaking and independent since 1988

INKhealthmatters is a member of INK, the Independent News Collective, trade association of the UK alternative press.

Last updated: 22 February 2007

XHTML1 | CSS2

RSS feed